Tren Depot by Pharm-Tec
M-Bolone, Metribolon, Methyltrenbolon, Methyltrenbolone, M3, R1881, R-1881, Metribolone
In Methyltrienolone is an orally applicable steroid which was developed in the sixties for use in animal and cell experiments. The synthesis was first described in 1963.
Methyltrienolone is often referred to as Methyltrenbolon, since it is structurally analogous to the steroid trenbolone, but has a methylene group more.
To market in human medicine, it was not developed because it excessive side effects (especially liver damage – methyltrienolone is one of the Leberschädlichsten steroids at all), which meant that testing on humans were discontinued quickly. In the bodybuilding scene, however it is known.
The strong effect of methyltrienolone based on the fact that it is not bound by albumin or SHBG (sex hormone binding globulin) in the body. By comparison, albumin and SHBG bind in the body between 96% and 98% of the body’s own testosterone. While the testosterone is present in bound form, it is not active.
Since methyltrienolone can not be bound, it is active at 100%.
Tren Depot primarily increases the aggressiveness and thus the willingness to go in training the limit. In addition methyltrienolone shortens recovery time. An athlete requires shorter breaks and thus can exercise more often. Since methyltrienolone due to its structure in the body can not be converted by aromatase into estrogen drop off unwanted water retention. For this reason methyltrienolone is used for pre-contest or diet.
Methyltrienolone was first detected in 2008 at a athletes. Basically, it is easily detectable. However, there is the possibility methyltrienolone modified so that it is very difficult to prove for experts. It should be noted that the doping effect is not taken into mitt passion.
Backflow of bile acid in the liver, liver enzymes, blood in urine, increased aggressiveness, acne, hair growth, hair loss, insomnia, loss of libido, excessive sweating, gynecomastia